Results 91 to 100 of about 55,201 (251)

Real‐World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry

American Journal of Hematology, Volume 101, Issue 5, Page 939-948, May 2026.
ABSTRACT Ravulizumab, a second‐generation complement component 5 inhibitor (C5i) derived from eculizumab, with improved pharmacokinetics, is the current standard‐of‐care treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), where available.
Alexander Röth, Christopher J. Patriquin, Jeff Szer, Louis Terriou, Ami S. Patel, Jesse Metzger, Philippe Gustovic, Jun‐ichi Nishimura, Robert A. Brodsky   +8 more
wiley   +1 more source

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

Cardiology and Therapy
Introduction The V-GOOD study evaluated the effectiveness of trimetazidine modified-release (MR) 80 mg once daily (OD) in patients with chronic coronary syndrome (CCS) who remained symptomatic despite antianginal therapies in routine clinical practice ...
Luís Henrique Wolff Gowdak, Paulo Magno Martins Dourado, Dalton Bertolim Précoma, César de Oliviera Lopes Dusilek, Francisco Maia da Silva, Juan Carlos Yugar-Toledo, Felipe Montes Pena, Domingos Antônio de Almeida Gomes, Elizabeth do Espírito Santo Cestário, Olavo Raimundo Guimarães, Conrado Roberto Hoffmann Filho, Carlos Filinto de Almeida, Flávio de Souza Brito, Gerez Fernandes Martins, Victor Rodrigues Ribeiro Ferreira, Marcella Chaves Flores, Mayara Lídia da Silva, on behalf of the V-GOOD Investigators   +17 more
doaj   +1 more source

Batch Size Effects on Mid‐2025 State‐of‐the‐Art Large Language Model Performance in Automated Title and Abstract Screening

Cochrane Evidence Synthesis and Methods, Volume 4, Issue 3, May 2026.
ABSTRACT Background Manual abstract screening is a primary bottleneck in evidence synthesis. Emerging evidence suggests that large language models (LLMs) can automate this task, but their performance when processing multiple references simultaneously in “batches” is uncertain.
Petter Fagerberg, Oscar Sallander, Kim Vikhe Patil, Anders Berg, Anastasia Nyman, Natalia Borg, Thomas Lindén   +6 more
wiley   +1 more source

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT

Российский кардиологический журнал, 2009
Aim. To investigate effectiveness and safety of trimetazidine MB in the complex treatment of stable angina. In total, 90 patients were examined – 57 women and 33 men aged 48-70 years (mean age 61,4 ± 6,03 years).
N. A. Shostak, O. G. Smolenskaya, A. V. Panov, A. A. Klimenko, D. Yu. Andriyashkina, N. A. Tverdova   +5 more
doaj  

The Physiology of Lived Experience: And then there was one – the story of a radical nephrectomy

Experimental Physiology, EarlyView.
Michael J. Shattock
wiley   +1 more source

Fungal Polysaccharides as Next‐Generation Bioactive: Advances in Structure–Activity Mapping, Mode of Action, and Biotechnological Horizons

Food Frontiers, Volume 7, Issue 3, May 2026.
ABSTRACT Fungal polysaccharides (FPs) represent a diverse class of bioactive macromolecules widely studied for their nutritional, therapeutic, and biotechnological value. This review synthesizes recent advances (2020–2025) in the structural characterization, biological functions, and translational potential of FPs.
Muhammad Aaqil, Feng Zhang, Jingchuan Zheng, Muhammad Kamil, Yuwei Guo, Cunchao Zhao, Yang Tian   +6 more
wiley   +1 more source

Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Salvia miltiorrhiza (Danshen) contains bioactive tanshinones, including tanshinone IIA, cryptotanshinone, and tanshinone I, that exert cardioprotective effects through coordinated modulation of vascular endothelial growth factor receptor (VEGFR), transforming growth factor beta 1 (TGF‐β1), transforming growth factor beta receptor (TGF‐βR), toll‐like ...
Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi, William N. Setzer, Javad Sharifi‐Rad, Daniela Calina   +6 more
wiley   +1 more source

Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina

Кардиоваскулярная терапия и профилактика, 2007
Aim. To study the effects of ACE inhibitor perindopril on circadian dynamic of heart rate variability (HRV) in patients with coronary heart disease (CHD) and stable effort angina. Material and methods.
N. A. Shardanov, E. K. Arsagova, L. M. Batyrbekova, M. Kh. Kurdanova, Kh. A. Kurdanov   +4 more
doaj  

Research and Scholarly Methods: Scoping Reviews

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 5, May 2026.
ABSTRACT Scoping reviews are similar to systematic reviews in that they are designed to be transparent and reproducible processes to answer a question while reducing bias. The key difference between scoping reviews and the better‐known systematic review method is the scope of the question being answered.
Jason B. Reed, Amina Ammar, Christopher Giuliano   +2 more
wiley   +1 more source

Utility of ranolazine in chronic stable angina patients

Vascular Health and Risk Management, 2008
Pawan D Patel, Rohit R AroraDepartment of Cardiology, Chicago Medical School, North Chicago, IL, USAAbstract: Chronic stable angina is a debilitating illness affecting at least 6.6 million US residents.
Pawan D Patel, Rohit R Arora
doaj